Maynard Um
-
-
-
-
-
-
-
Novo Nordisk Is Said To Sweeten Bid For Obesity Startup Metsera - Bloomberg
-
-
-
-
-
-
-
Pfizer (PFE) CEO: our bid for Metsera has taken into consideration that prices of GLP-1 will probably start going down - Conference Call
-
-
-
-
-
-
-
Pfizer sues Metsera directors and Novo Nordisk over merger breach
-
-
-
-
-
-
-
Novo Nordisk submits $6.5 billion offer for Metsera
-
-
-
-
-
-
-
Wolfe Research Comments on Path Forward for Pfizer (PFE) and Metsera (MTSR)
-
-
-
-
-
-
-
Chardan Comments on iBio, Inc. (IBIO)
-
-
-
-
-
-
-
Cantor Fitzgerald says more options, newer targets will expand obesity market
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

